SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing significant bullish momentum after securing its largest-ever defense contract from the U.S. Space Development Agency to build missile-tracking satellites, alongside achieving a record 21 successful Electron rocket launches. The community is actively discussing the company's strategic evolution into a vertically integrated space prime contractor, a move that is reshaping its role within the rapidly expanding space economy and generating strong long-term confidence.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to the imminent launch of its BlueBird 6 satellite and the recent shipment of BlueBird 7 to Cape Canaveral, signaling the start of an accelerated deployment cadence. The community is highly bullish, anticipating significant price movements as the company executes its plan to deliver space-based cellular broadband directly to smartphones, with many touting its unique technology and lack of direct competition.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining is currently trending after announcing it has become debt-free, a move celebrated by investors who are also noting significant insider buying by Eric Sprott. The community is buzzing with anticipation over the company's vast gold and silver reserves and ongoing exploration, especially given the backdrop of rising precious metal prices. Many believe HYMC is poised for substantial future gains, fueled by strong institutional ownership and a clear roadmap for mine development.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is a major topic of conversation as political rhetoric intensifies around healthcare costs, with recent comments from a prominent political figure about forcing insurers to cut prices creating significant investor apprehension. The community is sharply divided, with some fearing substantial impacts on profitability and potential stock declines, while others argue UNH is fundamentally strong, undervalued, and unlikely to be significantly affected by political posturing or the expiring ACA subsidies given its diversified business model. This ongoing debate highlights the broader context of evolving healthcare policy and its perceived influence on the sector.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is currently trending due to a significant contract award from the Department of War and a substantial private placement, which is strengthening its position in the defense and aerospace additive manufacturing sector. The community is actively discussing the company's unique technology for producing complex parts and its anticipated path to profitability, driven by growing demand from strategic partnerships. This convergence of events underscores Velo3D's perceived potential as a critical player in national security and space initiatives.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is experiencing extreme volatility as natural gas prices react to rapidly shifting winter weather forecasts. Bulls are buying the dip, betting on a reversal due to the start of winter and demand from LNG and data centers, while bears are capitalizing on unexpectedly mild forecasts and increased production, reinforcing BOIL's "widowmaker" reputation.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending due to a leadership transition as Dr. Kang Sun retires, with Tom Stepien taking over as CEO, and the recent expansion of its South Korea Battery Alliance to boost production capacity. The community is actively discussing the implications of insider share sales and the company's potential within the rapidly growing market for high-energy-density silicon anode batteries for applications like drones and electric aviation.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo (OKLO) is experiencing significant attention as investors weigh its potential in the nuclear energy sector against substantial financial moves. Bulls are optimistic about recent DOE approvals, analyst upgrades, and the broader narrative of small modular reactors powering AI, with founders signaling strong project milestones. However, concerns persist among bears regarding multi-billion dollar share offerings, insider selling, and the company's pre-revenue status, sparking debate over potential dilution and long-term valuation.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending due to renewed acquisition speculation, with reports circulating that Eli Lilly is exploring a potential takeover of the French biotech. This M&A chatter is amplifying investor interest following strong Phase 3 data for its ulcerative colitis drug, obefazimod, which initially sent shares soaring. The community is actively debating potential buyout prices and the implications for shorts who bet against the stock's underlying clinical strength.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as gold prices continue to challenge and set new all-time highs, fueled by mounting global economic uncertainties and escalating geopolitical tensions. Community discussion highlights strong safe-haven demand, with many viewing gold's robust performance as a direct response to a weakening economy, central bank buying, and potential shifts in monetary policy. Traders are actively debating continuation patterns and historical "Santa rally" bullishness, while also noting the broader context of a deepening global debt crisis and a shift away from traditional fiat assets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$EQIX
Current: $758.51
Entry: $759.73
Target: $798.27
Potential: +5.1%
Horizon: 7 days

The content provided on https://stocksurger.com/ is for informational purposes only and does not constitute a recommendation to buy or sell any security.

fiioemnegh

Stocksurger

US Stock Investment | Terminal

StockTwits Web

Equinix Inc


Current: $758.51
Entry: $759.73
Target: $798.27
Potential: +5.1%
Horizon: 7 days

The content provided on 

 is for informational purposes only and does not constitute a recommendation to buy or sell any security.